Scientists hunt for hidden genetic causes of rare bleeding disorder
NCT ID NCT07674381
First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time
Summary
This study investigates inherited thrombocytopenias, rare conditions where low platelet counts cause bleeding problems. About half of patients have an unknown genetic cause. Researchers aim to identify new disease genes and build a lab-grown bone marrow model to test how well drugs like Eltrombopag might work for each person. The goal is to improve diagnosis and personalize future treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could uncover new genetic forms of inherited thrombocytopenias and enable personalized treatment predictions.
- What could go wrong
- This is an observational and laboratory-based study, not a treatment trial. Findings may not translate into immediate clinical benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INHERITED THROMBOCYTOPENIAS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medicina Generale 1, Fondazione IRCCS Policlinico San Matteo
Pavia, 27100, Italy